Discover Tenders by Artificial Parts Body Sector

Find the most relevant tenders for Artificial Parts Body. Access the latest tender notices from various government and private organizations published across hundreds of websites and newspapers.Obtain complete and accurate information on Artificial Parts Body tenders, including all tender documents, RFPs, RFQs,and more. Utilize our advanced filters to search for Artificial Parts Body tenders by organization, tender value, opening and closing dates, and more.

Filter Your Search

Country

Sector

Region

Funding Agency

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Rivaroxaban B01Af01 Only Film Coated Tablets Excluding Potency 2 5Mg As Part Of A So Calle

Deadline: 31 Jan 2026

Germany

Ref. No.: 3943332

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Adalimumab L04Ab04 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940896

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Infliximab L04Ab02 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940617

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicinal Products With The Active Ingredient Rivaroxaban B01Af01 With An Effective Strength Of 2 5 Mg Per Divided Dosage Form

Deadline: 31 Jan 2026

Germany

Ref. No.: 3940204

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Rivaroxaban B01Af01 Only Hard Capsules Excluding Potency 2 5Mg As Part Of A So Called Open

Deadline: 31 Jan 2026

Germany

Ref. No.: 3939962

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Botulinum Toxin Type A M03Ax21 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3936784

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8 130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Etanercept L04Ab01 As Part Of A So Called Open House Model

Deadline: 31 Jan 2026

Germany

Ref. No.: 3934657

EMD:Ref Document

Bid Value: Ref Document

53 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Dexamethasone Exclusively Imp Atc S01Ba01 For The Period April 1St 2024 March 31St 2026

Deadline: 05 Feb 2026

Germany

Ref. No.: 3882718

EMD:Ref Document

Bid Value: Ref Document

58 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Interferon Beta 1B Atc L03Ab08 For The Period April 1St 2024 March 31St 2026

Deadline: 05 Feb 2026

Germany

Ref. No.: 3882267

EMD:Ref Document

Bid Value: Ref Document

58 Days Left

Ballast Shards For Railways

Deadline: 31 Dec 2031

Denmark

Ref. No.: 3881368

EMD:Ref Document

Bid Value: Ref Document

2213 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Estriol Exclusively Vcr Atc G03Cd01 For The Period April 1St 2024 March 31St 2026

Deadline: 05 Feb 2026

Germany

Ref. No.: 3881044

EMD:Ref Document

Bid Value: Ref Document

58 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Rivaroxaban Atc B01Af01 For The Period April 1St 2024 March 31St 2025 Plus Extension Option 1X12 Months

Deadline: 05 Feb 2026

Germany

Ref. No.: 3879402

EMD:Ref Document

Bid Value: Ref Document

58 Days Left

Conclusion Of A Non Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Filgrastim Atc L03Aa02 For The Period April 1St 2024 March 31St 2026

Deadline: 05 Feb 2026

Germany

Ref. No.: 3878300

EMD:Ref Document

Bid Value: Ref Document

58 Days Left

Afwerx Challenge Commercial Solutions Opening Cso

Deadline: 23 Feb 2028

United States

Ref. No.: 3877057

EMD:Ref Document

Bid Value: Ref Document

806 Days Left

Rfe Subscription To National Proffesional Body

Deadline: 01 Feb 2029

Great Britain

Ref. No.: 3853415

EMD:Ref Document

Bid Value: Ref Document

1150 Days Left

Showing 68446 to 68460 of 68531 results

‹
1
2
...
4560
4561
4562
4563
4564
4565
4566
4567
4568
4569
›

Discover Tenders by Artificial Parts Body Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Artificial Parts Body Sector

Filter Your Search

FREE Trial plan for all new users!